date,title,source
Oct-19-18,Mallinckrodt (MNK) Gets $26 Million as Funding From BARDA,Zacks
Oct-22-18,[$$] Medicines Co. Spinout Qpex Biopharma Raises $33 Million Series A,The Wall Street Journal
Oct-29-18,[$$] Budget 2018: The chancellors speech,Financial Times
Nov-01-18,The Medicines Company to Announce Third-Quarter 2018 Financial Results on November 8,Business Wire
Nov-05-18,"Report: Exploring Fundamental Drivers Behind SkyWest, Blueprint Medicines, HP, Hewlett Packard Enterprise, Cardinal Health, and The Medicines  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-08-18,"Alnylam's (ALNY) Q3 Loss Narrower Than Expected, Sales Miss",Zacks
Nov-08-18,"Medicines Co. (MDCO) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-08-18,Medicines Co.: 3Q Earnings Snapshot,Associated Press
Nov-08-18,The Medicines Company Reports Third-Quarter 2018 Results,Business Wire
Nov-09-18,Company Profile for The Medicines Company,Business Wire
Nov-09-18,Edited Transcript of MDCO earnings conference call or presentation 8-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-12-18,"Medicines Company (MDCO) Q3 Loss Widens, Inclisiran in Focus",Zacks
Nov-19-18,[$$] Pharma leaders warn Brexit deal lacks detail needed for patient safety,Financial Times
Nov-20-18,Edited Transcript of MDCO earnings conference call or presentation 8-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Dec-04-18,[$$] Government prepares to ration ferry space under no-deal Brexit,Financial Times
Dec-11-18,The Medicines Co. names Mark Timney CEO effective immediately,MarketWatch
Dec-11-18,The Medicines Company Appoints Mark Timney as Chief Executive Officer,Business Wire
Dec-12-18,The Medicines Company Announces Intention to Offer $150 Million of Convertible Notes,Business Wire
Dec-13-18,The Medicines Company Prices $150 Million of Convertible Notes,Business Wire
Dec-13-18,Here's Why Shares of The Medicines Company Sank 14.5% Today,Motley Fool
Dec-18-18,"The Medicines Co (MDCO) CEO Mark Timney Bought $499,652 of Shares",GuruFocus.com
Dec-24-18,Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III,Zacks
Jan-03-19,Implied Volatility Surging for Medicines Company (MDCO) Stock Options,Zacks
Jan-07-19,The Medicines Company Announces 5th Review of Un-blinded Data and Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase 3 Trials,Business Wire
